Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atrium Therapeutics, Inc. - Common Stock (NQ:RNA)

8.000 +0.030 (+0.38%)
Delayed Quote Updated: 9:30 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atrium Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
2 Potentially High-Reward Growth Stocks to Buy Right Now ↗
These two biotechnology stocks could be gearing up for a run. 
Via The Motley Fool
News headline image
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound ↗
Discover three top Nasdaq stocks to buy. Learn about these investment opportunities and why they’re worth your attention. 
Via InvestorPlace
News headline image
RNA Stock Earnings: Avidity Biosciences Misses EPS, Beats Revenue for Q1 2024 ↗
RNA stock results show that Avidity Biosciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Navigating 7 Analyst Ratings For Avidity Biosciences ↗
 
Via Benzinga
News headline image
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation ↗
 
Via Benzinga
Topics ETFs
News headline image
Where Avidity Biosciences Stands With Analysts ↗
 
Via Benzinga
News headline image
A Closer Look at 5 Analyst Recommendations For Avidity Biosciences ↗
 
Via Benzinga
News headline image
This Demand Zone In S&P 500 Needs To Hold ↗
Find out the demand zone that the S&P 500 needs to hold to avoid a meaningful pullback. 
Via Talk Markets
Topics Stocks
News headline image
Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge ↗
Cantor Fitzgerald initiates coverage on Avidity Biosciences highlighting a robust pipeline led by del-desiran, a promising treatment for Myotonic dystrophy type 1. With strong management, proven... 
Via Benzinga
News headline image
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Avidity Biosciences Says Lead Program Shows Reversal Of Disease Progression In Neuromuscular Disease ↗
New AOC 1001 data from Avidity Biosciences show reversal of disease progression in DM1 patients, using key endpoints in Phase 3 HARBOR trial. 
Via Benzinga
News headline image
Top 2% Biotech Avidity Collapses Despite 'Positive' Results In Treating Muscular Dystrophy ↗
The company is working on a treatment for myotonic dystrophy type 1, a form of muscular dystrophy. 
Via Investor's Business Daily
News headline image
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its... 
Via Benzinga
News headline image
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. 
Via Benzinga
Topics Stocks
News headline image
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
News headline image
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. 
Via Benzinga
Topics Stocks
News headline image
Top 3 Health Care Stocks You May Want To Dump In Q1 ↗
As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
News headline image
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge ↗
Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps. 
Via Benzinga
Topics Economy Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
3 Highly Rated Biotech Stocks to Buy for 300% Gains ↗
Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings. 
Via InvestorPlace
News headline image
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering. 
Via Benzinga
News headline image
FCEL Stock Alert: FuelCell Energy Announces AI Deal With IBM ↗
FuelCell Energy stock is climbing higher on Tuesday as investors in FCEL celebrate the company signing a deal with IBM! 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts ↗
Novocure layoffs are coming for 13% of the company's workers as it seeks to reduce its headcount by 200 people to reduce costs. 
Via InvestorPlace
Topics Workforce
News headline image
Lion Electric Layoffs 2023: What to Know About the Latest LEV Job Cuts ↗
Lion Electric layoffs are coming for 150 of the electric bus company's employees as it seeks to reduce its headcount by 10%. 
Via InvestorPlace
Topics Electric Vehicles Workforce
News headline image
Why Is Avidity Biosciences (RNA) Stock Up 15% Today? ↗
RNA stock is jumping over 15% in early trading after Avidity announced its expanded alliance with Bristol-Myers Squibb. 
Via InvestorPlace
News headline image
PDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
US Stocks Mixed; House Prices Rise In September ↗
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 10 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.04% to 35,345.85 while the NASDAQ fell... 
Via Benzinga
Topics Stocks
News headline image
Why Is RNA Therapeutics-Focused Avidity Biosciences Stock Trading Higher Today? ↗
Avidity Biosciences Inc (NASDAQ: RNA) announced a global licensing and research collaboration with Bristol Myers Squibb & Co (NYSE: BMY) focused on discovering, developing, and commercializing multiple... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to dive into the biggest pre-market stock movers for Tuesday morning with all of the latest news you need to know today! 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.